Elaine C Oliveira
Overview
Explore the profile of Elaine C Oliveira including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
211
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lima A, Ferrari B, Pradella F, Carvalho R, Rivero S, Quintiliano R, et al.
Front Immunol
. 2024 May;
15:1391949.
PMID: 38765015
Dimethyl fumarate (DMF, Tecfidera) is an oral drug utilized to treat relapsing-remitting multiple sclerosis (MS). DMF treatment reduces disease activity in MS. Gastrointestinal discomfort is a common adverse effect of...
2.
Chaves I, Baeta T, Dolabella G, Barbosa L, Almeida N, Oliveira F, et al.
Eur J Contracept Reprod Health Care
. 2021 Jun;
26(5):399-403.
PMID: 34096433
Purpose: This study aimed to assess the pain scores at the insertion of the 52 mg levonorgestrel-releasing intrauterine system (LNG-IUS) among nulligravidas, parous women with previous vaginal delivery and parous...
3.
Longhini A, Santos M, Pradella F, Moraes A, Dionete A, Andrade M, et al.
CNS Neurosci Ther
. 2014 Jun;
20(8):787-90.
PMID: 24931054
No abstract available.
4.
Moraes A, Paula R, Pradella F, Santos M, Oliveira E, von Glehn F, et al.
CNS Neurosci Ther
. 2013 Jun;
19(9):682-7.
PMID: 23731464
Background: Both Th1 and Th17 cells specific for neuroantigen are described as encephalitogenic in the experimental autoimmune encephalomyelitis (EAE) model. Aim: The proposal of this study was to investigate how...
5.
Farias A, Spagnol G, Bordeaux-Rego P, Oliveira C, Fontana A, de Paula R, et al.
CNS Neurosci Ther
. 2013 Mar;
19(4):269-77.
PMID: 23521914
Background: A growing body of evidence supports the hypothesis that vitamin D is an important environmental factor in the etiology of T-cell-mediated autoimmune diseases such as multiple sclerosis (MS). Aim:...
6.
Ruocco H, Brandao C, Farias A, Oliveira C, Oliveira E, Cendes F, et al.
Neuroimmunomodulation
. 2012 Apr;
19(5):277-82.
PMID: 22472803
Objective: The pathological hallmarks of multiple sclerosis (MS) lesions are inflammation, demyelination, axon loss and gliosis. The aim of this study was to verify the relation of brain lesion load...
7.
von Glehn F, Farias A, de Oliveira A, Damasceno A, Longhini A, Oliveira E, et al.
Mult Scler
. 2011 Nov;
18(7):1038-41.
PMID: 22041091
Intrathecal immunoglobulin synthesis in an oligoclonal pattern is the most common immunologic abnormality detected in MS patients. Various treatments, such as immunomodulators and immunosuppressors, have not been found to modify...
8.
Grecco A, Paula R, Mizutani E, Sartorelli J, Milani A, Longhini A, et al.
Nanotechnology
. 2011 May;
22(26):265103.
PMID: 21576788
Our data demonstrate that multi-walled carbon nanotubes (MWCNTs) are internalized by macrophages, subsequently activating them to produce interleukin (IL)-12 (IL-12). This cytokine induced the proliferative response of T lymphocytes to...
9.
Longhini A, von Glehn F, Brandao C, de Paula R, Pradella F, Moraes A, et al.
J Neuroinflammation
. 2011 Jan;
8(1):2.
PMID: 21214939
The plasmacytoid dendritic cells (pDCs) express a high level of Toll-like receptor 9 (TLR-9), which recognizes viral DNA. Activated via TLR-9, pDCs also secrete large amounts of type I interferon...
10.
Mirandola S, Hallal D, Farias A, Oliveira E, Brandao C, Ruocco H, et al.
Int Immunopharmacol
. 2009 Mar;
9(7-8):824-30.
PMID: 19289181
Immunotherapy with Interferon-beta (IFNbeta) results in remarkably beneficial effects in patients with relapsing-remitting multiple sclerosis (MS), although the mechanisms by which it exerts these beneficial effects remain poorly understood. An...